services · stock-sale · portfolio-rebalancing
Rep. Julie Johnson Avoids Accenture Decline With Well-Timed May Sale
The Texas Democrat sold her shares in the IT consulting giant just weeks before the stock slid nearly 25 percent.
2026-06-26 — Julie Johnson · ACN
Key facts
- Rep. Julie Johnson sold between $1,001 and $15,000 of Accenture plc (ACN) on May 12, 2026.
- Since the transaction, the stock has declined by approximately 24.8 percent.
- Johnson also sold Abbott Laboratories stock on the same day, indicating routine portfolio rebalancing.
- The representative's high-volume trading profile (501 trades across 227 tickers) suggests her account is managed by an external adviser.
Rep. Julie Johnson (D-Texas), a freshman lawmaker who took office in January 2025, executed a perfectly timed exit from Accenture plc (ACN) in the spring of 2026. On May 12, 2026, Johnson sold between $1,001 and $15,000 of her shares in the IT consulting giant. Since that transaction, Accenture's stock has slid nearly 25 percent, falling from $169.77 on the day of her sale to $127.74.
The defensive transaction spared the representative from a significant market decline. The sale occurred in the wake of routine corporate disclosures from Accenture, including a March earnings statement and an April filing detailing new credit agreements.
However, our analysis suggests this impeccable timing may be the byproduct of automated portfolio management rather than a targeted trade. Johnson is an exceptionally active trader, logging 501 transactions across 227 unique tickers over a 16-month period. This high-churn pattern of small, uniform trades strongly indicates the account is run by an external financial adviser. Furthermore, Johnson sold an identical range of Abbott Laboratories (ABT) stock on the exact same day, pointing to routine portfolio rebalancing or cash generation.
Johnson’s trading history also shows a pattern of systematic divestment rather than sudden speculation. She has only ever sold Accenture stock, previously executing four identical sales in March 2025.
While Johnson serves on the House Homeland Security Committee, which oversees federal IT procurement and cybersecurity policy, this connection is highly tangential. Accenture Federal Services frequently competes for government contracts, but the committee does not exercise direct regulatory oversight over Accenture’s core global operations. Under the STOCK Act, members of Congress are required to disclose trades within 45 days, and transactions are reported in broad ranges. Johnson filed her disclosure on June 12, 2026, representing a standard 31-day lag.
She is also not alone in trimming her holdings. Several other lawmakers have recently reported sales of Accenture, including Reps. Richard W. Allen (R-Ga.) and Kevin Hern (R-Okla.).
For a freshman lawmaker, sometimes the best market defense is a quiet, managed index.
Sources
- Accenture plc Form 8-K (March 19, 2026) — SEC EDGAR
- Accenture plc Form 8-K (April 24, 2026) — SEC EDGAR